Activation of nuclear factor-kappaB in macrophages by mycoplasmal lipopeptides

Eur J Immunol. 1998 Dec;28(12):4207-12. doi: 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R.

Abstract

Mycoplasmas are potent macrophage stimulators. The active principle are lipopeptides or lipoproteins with a characteristic N-terminal S-[dihydroxypropyl]-cysteinyl group bearing two ester-bound fatty acids and lacking the amide-bound one common to other bacterial lipoproteins. Using synthetic analogues of mycoplasmal lipopeptides, we investigated activation of the transcription factor NF-kappaB in the C3H/HeJ mouse-derived DMBM-3 cell line. The lipopeptides activated NF-kappaB at below nanomolar concentrations. Activation in the murine system occurred distinctly earlier than TNF-alpha liberation, excluding autocrine stimulation by TNF-alpha. As determined from a supershift experiment, the active NF-kappaB complex consisted of the heterodimer p50/p65(RelA). The relevance of these findings for the inflammatory response to mycoplasmas and for mycoplasma-mediated effects on HIV-infected macrophages is discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Proteins / immunology
  • Bacterial Proteins / pharmacology
  • Cell Line
  • Lipoproteins / immunology
  • Lipoproteins / pharmacology*
  • Macrophage Activation / drug effects
  • Macrophage Activation / immunology*
  • Macrophages / immunology*
  • Mice
  • Mycoplasma
  • NF-kappa B / immunology*

Substances

  • Bacterial Proteins
  • Lipoproteins
  • NF-kappa B